You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRS

Showing 26 - 50 of 1,905
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR), Truvada Tablet)

Active, not recruiting
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Feb 1, 2023

HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

Recruiting
  • HIV Infection
  • N-803 (IL-15 Superagonist)
  • +2 more
  • Los Angeles, California
  • +11 more
Sep 22, 2022

HIV Trial in Worldwide (Dolutegravir 0.5 mg/kg oral suspension, Dolutegravir 5 mg Dispersible Tablets)

Recruiting
  • HIV
  • Dolutegravir 0.5 mg/kg oral suspension
  • Dolutegravir 5 mg Dispersible Tablets
  • Los Angeles, California
  • +17 more
Nov 10, 2022

HIV-1-infection Trial in Worldwide (TI-CBT Intervention Arm, Discussion Control Arm)

Not yet recruiting
  • HIV-1-infection
  • TI-CBT Intervention Arm
  • Discussion Control Arm
  • Gaborone, Botswana
  • +7 more
Sep 23, 2022

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)

Not yet recruiting
  • Tuberculosis
  • HIV Infections
  • VPM1002 Vaccine
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +8 more
Sep 14, 2022

Rhinosinusitis Chronic, Polyp, Nasal Trial in Spain (Mepolizumab, Polypeptomy)

Not yet recruiting
  • Rhinosinusitis Chronic
  • Polyp, Nasal
  • Bilbao, Spain
  • +6 more
Jun 19, 2023

Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemo, Hydration Trial in Beijing (Urine-guided hydration, Routine

Not yet recruiting
  • Cytoreductive Surgery
  • +5 more
  • Urine-guided hydration
  • +3 more
  • Beijing, China
    Aerospace Center Hospital
Jul 11, 2023

HIV Trial in South Africa, Thailand, United States (Doravirine (DOR), Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate

Completed
Has Results
  • HIV Infections
  • Doravirine (DOR)
  • +2 more
  • Aurora, Colorado
  • +7 more
Sep 30, 2022

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

Recruiting
  • HIV Infections
  • +2 more
  • Letermovir 240 MG Oral Tablet
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jun 20, 2022

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR)-004, Truvada Tablet)

Completed
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)-004
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Nov 17, 2022

HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

Recruiting
  • HIV Infection
  • Analytical Treatment Interruption
  • Gaborone, Botswana
  • +10 more
May 16, 2022

Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

Not yet recruiting
  • Tuberculosis
  • Rifampicin Resistant Tuberculosis
  • Pretomanid
  • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
  • Rio De Janeiro, Brazil
  • +6 more
Oct 18, 2022

HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

Completed
Has Results
  • HIV Infections
  • Placebo for maraviroc (MVC)
  • +3 more
  • Los Angeles, California
  • +29 more
Apr 20, 2022

HIV Trial in Worldwide (Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), Behavioral HIV risk reduction package)

Recruiting
  • HIV Infections
  • Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
  • Behavioral HIV risk reduction package
  • Blantyre, Malawi
  • +6 more
Jun 20, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV-MVA Triplex
  • Placebo
  • Birmingham, Alabama
  • +11 more
Jun 20, 2022

HIV Trial in South Africa (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Placebo)

Completed
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +2 more
  • Mthatha, Eastern Cape, South Africa
  • +13 more
May 17, 2022

Colon Cancer, Ovarian Cancer, GI Cancer Trial in Hershey (Home-based Exercise Program Prior to CRS-HIPEC, Exercise Education)

Recruiting
  • Colon Cancer
  • +3 more
  • Home-based Exercise Program Prior to CRS-HIPEC
  • Exercise Education
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center
Mar 28, 2022

HIV-associated Tuberculosis Trial in South Africa, Thailand (Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC,

Not yet recruiting
  • HIV-associated Tuberculosis
  • Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC
  • +3 more
  • Mowbray, Cape Town, Western Cape, South Africa
  • +3 more
Nov 18, 2022

HIV Trial in Johannesburg, Kampala, Harare (Oral cabotegravir (CAB), CAB LA, Oral tenofovir disoproxil fumarate/emtricitabine

Active, not recruiting
  • HIV Infections
  • Oral cabotegravir (CAB)
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +2 more
Dec 13, 2022